HuagongsheHuagongshe Chemistry Print Report · For research reference only
Morpholine → 5,7-Dimethyl-2-[4-(4-morpholinyl)phenyl]-4-(3,4,5-trimethoxyphenoxy)imidazo-[5,1-f][1,2,4]triazine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | 2-(4-Bromophenyl)-5,7-dimethyl-4-(3,4,5-trimethoxyphenoxy)imidazo[5,1-f][1,2,4]triazine | HCID 12095701 | — |
| Reactant | Sodium t-butoxide | HCID 23676156 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | 5,7-Dimethyl-2-[4-(4-morpholinyl)phenyl]-4-(3,4,5-trimethoxyphenoxy)imidazo-[5,1-f][1,2,4]triazine | HCID 12096690 | — |
Reaction Conditions
| Temperature | 100 °C |
|---|
Reaction Steps
28 mg (0.29 mmol) of sodium tert-butoxide are introduced into a second Schlenk tube under argon. Subsequently, 100 mg (0.21 mmol) of 2-(4-bromophenyl)-5,7-dimethyl-4-(3,4,5-trimethoxyphenoxy)imidazo[5,1-f][1,2,4]triazine from Exam-ple 16A, 22 mg (0.25 mmol) of morpholine and 2 ml of anhydrous toluene are added. Solution A is likewise added, and the whole is stirred overnight at 100° C. After cooling, the mixture is then filtered off with suction through a glass frit. The filtrate is concentrated to dryness under reduced pressure and purified by flash chromatography (cyclohexane/ethyl acetate 10:1-4:1-3:2-1:1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07202243B2 |
| Source dataset | uspto-grants-2007_04 |
| ORD ID | ord-6dd3637906c246339276c5d7cf01db7d |
| Source note | uspto-grants-2007_04 |